Characterisation of the Novel HLA‐B*57:200 Allele by Sequencing‐Based Typing
HLA · 2026-03 · 107 (3)
DOI: 10.1111/tan.70606 ↗Kurz gefasst
Leserbrief in der Zeitschrift HLA, online erschienen am 25.02.2026. Verfasst von Intissar Dalhoumi und 4 weiteren Autor:innen. Beteiligte Einrichtung: CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 3 Literaturangaben.
Abstract (Originalsprache)
HLA‐B*57:200 differs from HLA‐B*57:01:01:01 by one nucleotide substitution in codon 7 in exon 2.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.
- CHU de Lille, Institut d'Immunologie-HLA, Bd du Professeur Jules Leclercq, Lille, France.
- Bordeaux University, CNRS, INSERM, ImmunoConcEpt, UMR 5164, Bordeaux, France.
Zitieren
APA
Dalhoumi, I., Elsermans, V., Top, I., Tenchon, O., & Visentin, J. (2026). Characterisation of the Novel HLA‐B*57:200 Allele by Sequencing‐Based Typing. HLA, 107(3). https://doi.org/10.1111/tan.70606
Vancouver
Dalhoumi I, Elsermans V, Top I, Tenchon O, Visentin J. Characterisation of the Novel HLA‐B*57:200 Allele by Sequencing‐Based Typing. HLA. 2026;107(3). doi:10.1111/tan.70606
BibTeX
@article{Dalhoumi2026,
author = {Dalhoumi, Intissar and Elsermans, Vincent and Top, Isabelle and Tenchon, Oceane and Visentin, Jonathan},
title = {Characterisation of the Novel HLA‐B*57:200 Allele by Sequencing‐Based Typing},
journal = {HLA},
year = {2026},
volume = {107},
number = {3},
doi = {10.1111/tan.70606}
}
EUVIMED